SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001140361-22-032232
Filing Date
2022-09-02
Accepted
2022-09-02 16:58:20
Documents
2
Group Members
FRANCESCO MICHELIPAOLO FUNDARO

Document Format Files

Seq Description Document Type Size
1 SC 13G/A brhc10041576_sc13ga.htm SC 13G/A 94877
2 EXHIBIT 1 brhc10041576_ex99-1.htm EX-99.1 6092
  Complete submission text file 0001140361-22-032232.txt   102564
Mailing Address 305 MADISON AVENUE MORRISTOWN NJ 07960
Business Address 305 MADISON AVENUE MORRISTOWN NJ 07960 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Subject) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87033 | Film No.: 221225927
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA G. DE GRASSI, 11 MILAN L6 20123
Business Address VIA G. DE GRASSI, 11 MILAN L6 20123 390236515110
Genextra S.p.A. (Filed by) CIK: 0001559515 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L6 | Fiscal Year End: 1212
Type: SC 13G/A